US Patent 7494660 HCV NS3-NS4A protease resistance mutants

Patent 7494660 was granted and assigned to Vertex Pharmaceuticals on February, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Vertex Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

74946600

Patent Inventor Names

Chao Lin0

Kai Lin0

Date of Patent

February 24, 2009

Patent Application Number

109745580

Date Filed

October 27, 2004

Patent Primary Examiner

‌

Stacy B. Chen

Patent abstract

The present invention is directed to mutants of HCV NS3/4A protease. More particularly, the present invention identifies mutant of HCV NS3/4A protease that are resistant to drug treatment.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7494660 HCV NS3-NS4A protease resistance mutants

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API